pediatric semaglutide Oral Lowers HbA1c in Phase 3 Trial in Youth With Type 2 Diabetes SEMAGLUTIDE FOR WEIGHT LOSS

Phase 2 Clinical Data (NEJM, 2023) The landmark Phase 2 Retatrutide trial (NEJM, June 2023) is the primary clinical evidence base for researcher interest in this compound

If you have lipedema and are considering this combination, work with a physician familiar with the condition

For many adults with obesity or weight-related health problems, the potential benefits of GLP-1 treatment can outweigh the risks when the medication is prescribed and monitored by a licensed provider

FDA accepts filing application for oral semaglutide 25 mg, which if approved, would be the first oral GLP-1 treatment for obesity

Its sometimes no fun when one of your favorite actors loses weight

A century later, it still reinforces privilege: Underrepresented students of color make up 12.5 percent of applicants at selective colleges but only 6.7 percent of the legacy applicant pool